Caraway Therapeutics logo

Caraway Therapeutics

HQ
Cambridge, Massachusetts, USA
25 Total Employees
Year Founded: 2018

Similar Companies Hiring

Pharmaceutical • Healthtech • Biotech • Big Data • Artificial Intelligence
New York, NY
140 Employees
Software • Healthtech • Biotech • Big Data • Artificial Intelligence
3 Offices
450 Employees
Pharmaceutical • Natural Language Processing • Machine Learning • Healthtech • Biotech • Artificial Intelligence
40 Offices
121990 Employees
A TARGETED APPROACH TO ACTIVATE CELLULAR CLEARANCE
Caraway’s therapeutic approach leverages genetic data and unique biological understanding to develop proprietary small molecules that activate cellular clearance and recycling processes – accelerating clearance of accumulated toxic materials and defective cellular components. New insights in genetics highlight the link between lysosomal function and pathologies in multiple organ systems, including the central nervous system (CNS), heart, kidney, and muscle. Caraway is a leader in targeting these mechanisms with potentially disease-modifying compounds for patients suffering the devastating effects of neurodegenerative and rare diseases including Parkinson’s disease (PD), Amyotrophic Lateral Sclerosis (ALS), and lysosomal storage diseases (LSDs).

Caraway Therapeutics Offices

OnSite Workspace

Employees work from physical offices.

Typical time on-site: None
HQCambridge, Massachusetts, USA